Didier Breyer

522 total citations
18 papers, 351 citations indexed

About

Didier Breyer is a scholar working on Molecular Biology, Plant Science and Genetics. According to data from OpenAlex, Didier Breyer has authored 18 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Plant Science and 5 papers in Genetics. Recurrent topics in Didier Breyer's work include CRISPR and Genetic Engineering (8 papers), Bacillus and Francisella bacterial research (6 papers) and Genetically Modified Organisms Research (5 papers). Didier Breyer is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), Bacillus and Francisella bacterial research (6 papers) and Genetically Modified Organisms Research (5 papers). Didier Breyer collaborates with scholars based in Belgium, Germany and France. Didier Breyer's co-authors include Katia Pauwels, Martine Goossens, Philippe Herman, Céline Verheust, Dirk Reheul, Lilya Kopertekh, Nancy Podevin, Dana Carroll, Myriam Sneyers and M.-R. Michel-Wolwertz and has published in prestigious journals such as Analytical Biochemistry, Plant Molecular Biology and Vaccine.

In The Last Decade

Didier Breyer

18 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didier Breyer Belgium 9 237 94 57 55 47 18 351
D. Thinès Belgium 9 362 1.5× 127 1.4× 80 1.4× 102 1.9× 87 1.9× 10 594
Bahram Arezi United States 10 373 1.6× 41 0.4× 87 1.5× 27 0.5× 49 1.0× 13 473
Dantong Zhu China 11 111 0.5× 92 1.0× 52 0.9× 29 0.5× 21 0.4× 21 360
Ouafa Zghidi‐Abouzid France 11 168 0.7× 158 1.7× 51 0.9× 43 0.8× 27 0.6× 18 391
Glen McIntyre Australia 10 295 1.2× 52 0.6× 78 1.4× 20 0.4× 30 0.6× 11 369
Demetrio Sánchez-Martı́nez United States 8 307 1.3× 395 4.2× 27 0.5× 150 2.7× 49 1.0× 11 673
Xidian Tang China 8 310 1.3× 48 0.5× 99 1.7× 57 1.0× 45 1.0× 11 431
J. L. Sears United States 10 99 0.4× 224 2.4× 42 0.7× 94 1.7× 28 0.6× 15 410
Luca Petiti Italy 11 229 1.0× 129 1.4× 77 1.4× 24 0.4× 49 1.0× 12 433

Countries citing papers authored by Didier Breyer

Since Specialization
Citations

This map shows the geographic impact of Didier Breyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Breyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Breyer more than expected).

Fields of papers citing papers by Didier Breyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Breyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Breyer. The network helps show where Didier Breyer may publish in the future.

Co-authorship network of co-authors of Didier Breyer

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Breyer. A scholar is included among the top collaborators of Didier Breyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Breyer. Didier Breyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Breyer, Didier, et al.. (2019). Opinion: Airtightness for Decontamination by Fumigation of High-Containment Laboratories. Applied Biosafety. 24(4). 207–212. 2 indexed citations
2.
Goossens, Martine, et al.. (2014). Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors. Current Gene Therapy. 13(6). 413–420. 17 indexed citations
3.
Breyer, Didier, Lilya Kopertekh, & Dirk Reheul. (2014). Alternatives to Antibiotic Resistance Marker Genes for In Vitro Selection of Genetically Modified Plants – Scientific Developments, Current Use, Operational Access and Biosafety Considerations. Critical Reviews in Plant Sciences. 33(4). 286–330. 48 indexed citations
4.
Baldo, Aline, et al.. (2013). Biosafety Risk Assessment and Management of Laboratory-Derived Influenza A (H5N1) Viruses Transmissible in Ferrets. Applied Biosafety. 18(1). 6–17. 2 indexed citations
5.
Pauwels, Katia, Nancy Podevin, Didier Breyer, Dana Carroll, & Philippe Herman. (2013). Engineering nucleases for gene targeting: safety and regulatory considerations. New Biotechnology. 31(1). 18–27. 64 indexed citations
6.
Pauwels, Katia, Catherine Golstein, Didier Breyer, et al.. (2013). Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology. Journal of Consumer Protection and Food Safety. 8(3). 215–226. 3 indexed citations
7.
Verheust, Céline, Martine Goossens, Katia Pauwels, & Didier Breyer. (2012). Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine. 30(16). 2623–2632. 81 indexed citations
8.
Pauwels, Katia, Didier Breyer, Adinda de Schrijver, Martine Goossens, & Philippe Herman. (2010). Contributions from scientific research to the risk assessment of GMOs. Lessons learned from a symposium held in Brussels, Belgium, 21–22 October 2010. PubMed. 9(3). 113–121. 2 indexed citations
9.
Breyer, Didier, Martine Goossens, Philippe Herman, & Myriam Sneyers. (2009). Biosafety considerations associated with molecular farming in genetically modified plants.. Journal of Medicinal Plants Research. 3(11). 825–838. 18 indexed citations
10.
Breyer, Didier, Philippe Herman, Annick Brandenburger, et al.. (2009). Commentary: Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?. PubMed. 8(2). 57–64. 27 indexed citations
11.
Breyer, Didier, et al.. (2007). Bringing scientists to the people – the Co‐Extra website. Biotechnology Journal. 2(9). 1081–1085. 1 indexed citations
12.
Herman, Philippe, Maryse Fauville‐Dufaux, Didier Breyer, et al.. (2006). Biosafety Recommendations for the Contained Use of Mycobacterium tuberculosis Complex Isolates in Industrialized Countries.. 8 indexed citations
13.
Herman, Philippe, Didier Breyer, B. Brochier, et al.. (2004). Biosafety Risk Assessment of the Severe Acute Respiratory Syndrome (SARS) Coronavirus and Containment Measures for the Diagnostic and Research Laboratories. Applied Biosafety. 9(3). 128–142. 6 indexed citations
14.
Maréchal, Daniel, et al.. (1993). A Subtractive Hybridization Method to Isolate Tissue-Specific Transcripts: Application to the Selection of New Brain-Specific Products. Analytical Biochemistry. 208(2). 330–333. 11 indexed citations
15.
Michel-Wolwertz, M.-R., Laurence Colleaux, Didier Breyer, et al.. (1992). Biochemical, genetic and molecular characterization of new respiratory-deficient mutants inChlamydomonas reinhardtii. Plant Molecular Biology. 18(4). 759–772. 49 indexed citations
16.
Remacle, Jacques, Didier Breyer, & Roland Loppes. (1988). Molecular cloning of the ARG7 gene of Schizosaccharomyces pombe encoding argininosuccinate lyase. Current Genetics. 14(4). 381–385. 2 indexed citations
17.
Breyer, Didier, et al.. (1972). [Suitability of the O-diphenol oxidase test using catechol for the differentiation of Cryptococcus neoformans].. PubMed. 222(4). 540–3. 6 indexed citations
18.
Staib, F., et al.. (1972). [Hay as a nutrient substratum for Cryptococcus neoformans].. PubMed. 222(3). 407–14. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026